Opinion

Video

The Patient Experience: From Symptoms to Diagnosis of Alzheimer Disease

Author(s):

Derek van Amerongen, MD, MS,Soeren Mattke, MD, DSc

The expert panel offers comprehensive insights on the patient journey for people with Alzheimer disease, highlighting symptoms, challenges, and the diagnostic process.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      1. [Dr Nair] Please describe the current patient journey for a patient with AD.Walk us through how and to which provider a patient may initially present and then how long before a patient receives a diagnosis. 
      Related Videos
      Jason Bellet of Eko Health
      Overcoming Ongoing Equity Challenges Through Remote Patient Monitoring
      Dr Geoffrey Rutledge
      Telehealth's Journey From Limited Use to a Health Care Essential
      3 experts are featured in this series.
      Managing Complexity: Standardizing Workflows for Multiple Bispecific Therapies
      CGM Coverage and Access
      CGM Coverage and Access
      5 experts are featured in this series
      Minimizing Antibiotic Resistance Development in Uncomplicated UTIs
      4 experts are featured in this series.
      Expanding Access to Alzheimer Disease Care: Leveraging Referral Networks and Telemedicine for Patients in Underserved Areas
      4 experts are featured in this series.
      From Time Constraints to Reimbursement: Addressing Key Hurdles in Cognitive Screening for Alzheimer Disease
      5 experts are featured in this series
      Patient Burden Associated With Uncomplicated UTIs
      Health Care System Integration
      Health Care System Integration
      1 expert is featured in this series.
      Tailoring HS Treatment: The Path to Better Patient Outcomes
      Related Content
      FDA approval-Olivier Le Moal-stock.adobe.com
      March 28th 2025

      FDA Approves Fitusiran for Reducing Bleeds in Patients With Hemophilia A/B

      Giuliana Grossi
      Data from the ATLAS research comprises a series of trials that have yielded years of long-term, comprehensive data on safety and efficacy.
      managed care cast logo
      December 23rd 2024

      Five Years Later: Ongoing COVID-19 Challenges, Next Steps

      Brooke McCormick
      On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
      Clinician documentation | Image Credit: - DC Studio - stock.adobe.com
      March 26th 2025

      Speech Recognition Tools May Boost Clinician Documentation Efficiency

      Brooke McCormick
      Documentation efficiency was higher among younger and male clinicians.
      Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
      December 17th 2024

      Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

      Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.
      FDA Approved. | Image Credit: wladimir1804 - stock.adobe.com
      March 26th 2025

      FDA Approves Cabozantinib for Advanced Pancreatic Neuroendocrine Tumors

      Giuliana Grossi
      With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer Network guidelines, this approval reinforces cabozantinib’s role in improving outcomes for patients facing these challenging cancers.
      Pulmonary hypertension | Image Credit: © Uladzislau-stock.adobe.com
      March 26th 2025

      PAH Therapies Improve Outcomes in PH-ILD

      Maggie L. Shaw
      Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among individuals who have idiopathic pulmonary fibrosis. Overall, most cases of PH in the setting of ILD are mild.

      2 Commerce Drive
      Suite 100
      Cranbury, NJ 08512

      © 2025 MJH Life Sciences® and AJMC®.
      All rights reserved.

      About
      Contact
      Editorial Boards
      Advertise
      Do Not Sell My Information
      Terms & Conditions
      Privacy Policy
      AJMC Managed Markets Network Logo
      CH LogoCenter for Biosimilars Logo